Search Within

Department of Medicine

Formats
  1. Journal Article (19618)
  2. Meeting Abstract (16046)
  3. Review (1158)
  4. Book Section (934)
  5. Editorial (611)
  6. Research Letter (316)
  7. Conference Paper (301)
  8. Guidelines (298)
  9. Correspondence (236)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22348)
  2. Hematologic Malignancies, Division of (13287)
  3. Center for Hematologic Malignancies (11069)
  4. GSK Faculty (10653)
  5. Survivorship Research (9346)
  6. Division of Subspecialty Medicine (7554)

More Groups

People
  1. Robert Motzer (1249)
  2. Howard Scher (1133)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (906)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1118)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4216)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2291)
  6. Nature Publishing Group (2121)

More Publishers

Results (39669)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Toward the development of molecular oncology: The integration of molecular epidemiology and environmental oncology
    Meeting Abstract

    Norton, L.
    Epidemiology (2004)

    Fulltext@MSK | Save
  • Hormonal induction followed by rapid hormonal cycling for prostate cancer (PC): The MEN's Cycle
    Meeting Abstract

    Nordquist, L.; Sauter, N.; Morris, M.; Smaletz, O.; Konopelski, K.; Delacruz, A.; Heller, G.; Scher, H. I.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Use of MR spectroscopy and functional imaging in the treatment planning of gliomas
    Meeting Abstract

    Narayana, A.; Chang, J.; Thakur, S.; Huang, W.; Kowalski, A.; Perera, G.; Karimi, S.; Holodny, A.; Hunt, M.; Amols, H.; more...
    International Journal of Radiation Oncology, Biology, Physics (2004)

    Fulltext@MSK | Save
  • Gene expression profiling of BRCA1-mutant human breast cancer cells after exposure to tamoxifen plus estrogen
    Meeting Abstract

    Murphy, C. D.; Olshen, A. B.; Chuai, S.; Viale, A.; Kim, S. W.; Borgen, P. I.; Hudis, C.; Boyd, J.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • The paradoxical effect of glucocorticoid-induced tumor necrosis factor receptor family-related gene (GITR) activation on alloreactive CD4 and CD8 T cells and the development of GVHD
    Meeting Abstract

    Muriglan, S. J.; Ramirez-Montagut, T.; Alpdogan, O.; Van Huystee, T.; Eng, J. M.; Hubbard, V. M.; Kochman, A. A.; Tjoe, K. H.; van den Brink, M. R. M.
    Biology of Blood and Marrow Transplantation (2004)

    Fulltext@MSK | Save
  • Sequential therapy with cytarabine and bismuth-213 (Bi-213)-labeled-HuM195 (anti-CD33) for acute myeloid leukemia (AML)
    Meeting Abstract

    Mulford, D. A.; Pandit-Taskar, N.; McDevitt, M. R.; Finn, R. D.; Weiss, M. A.; Apostolidis, C.; Morgenstern, A.; Divgi, C. R.; Larson, S. M.; Scheinberg, D. A.; more...
    Blood (2004)

    Fulltext@MSK | Save
  • Bismuth-labeled anti-CD33 antibody for elimination of minimal residual disease in acute myeloid leukemia
    Meeting Abstract

    Mulford, D.; Divgi, C.; Mcdevitt, M.; Sgouros, G.; Finn, R.; Larson, S.; Apostolidis, C.; Morgenstern, A.; Scheinberg, D.; Jurcic, J.
    Cancer Biotherapy and Radiopharmaceuticals (2004)

    Fulltext@MSK | Save
  • SUO11248, a novel tyrosine kinase inhibitor, shows antitumor activity in second-line therapy for patients with metastatic renal cell carcinoma: Results of a phase 2 trial
    Meeting Abstract

    Motzer, R. J.; Rini, B. I.; Michaelson, M. D.; Redman, B. G.; Hudes, G. R.; Wilding, G.; Figlin, R. A.; Zhu, J.; Kim, S. T.; Baum, C.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • The importance of molecular phenotype in predicting overall survival in patients with relapsed or primary refractory DLBCL treated with second-line chemotherapy and ASCT
    Meeting Abstract

    Moskowitz, C. H.; Kewalramani, T.; Hamlin, P.; Nimer, S. D.; Zelenetz, A. D.; Teruya-Feldstein, J.
    Blood (2004)

    Fulltext@MSK | Save
  • Phase I trial of exogenous testosterone (T) for the treatment of castrate metastatic prostate cancer (PC)
    Meeting Abstract

    Morris, M. J.; Kelly, W. K.; Slovin, S.; Sauter, N.; Eicher, C.; Regan, K.; Curley, T.; Delacruz, A.; Reuter, V.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save